The secondary market has already decided.
OpenAI is fetching a 10 percent discount to its $852 billion headline valuation — $765 billion in bids, with about $600 million of shares sitting unsellable, according to Next Round Capital, which fields secondary transactions for institutional investors. Anthropic, meanwhile, is commanding a 50 percent premium to its March Series G valuation, drawing $2 billion in ready capital and another $1.6 billion in Hiive demand at an implied $600 billion valuation, up from $380 billion post-money three months ago.
The divergence is visible in the pricing of access itself. Goldman Sachs is charging carry fees to clients seeking Anthropic shares, according to a person familiar with the matter. It is not charging carry to access OpenAI.
The numbers add up to a capital repricing that no investor survey could capture. Secondary markets are thin and the prices are not definitive — but the direction is unmistakable. Three independent platforms — Next Round Capital, Augment, and Hiive — are all telling the same story: OpenAI shares are a sellers' market with no buyers, while Anthropic shares have a queue.
That repricing creates pressure on the investors who need an IPO to realize returns. Microsoft, Thrive Capital, and SoftBank all hold stakes priced at the $852 billion level. If the secondary discount holds — and particularly if it widens before any public listing — the path to a successful IPO becomes narrower.
The governance signal reinforces the market signal. Sarah Friar, OpenAI's CFO since 2024, has been excluded from investor meetings after raising internal concerns about Sam Altman's proposed $600 billion spending vision and the 2026 IPO timeline. The Information first reported the exclusion. The friction between CFO and CEO on capital allocation and listing readiness is now visible to the same investors the company needs to price an IPO.
What the data does not tell us is whether the discount is permanent. OpenAI's $122 billion March fundraising included sovereign and tech-company backing that gives it more financial runway than any previous private AI company. The enterprise pivot that critics call a retreat could yet produce the revenue trajectory that justifies the valuation. And Anthropic's Pentagon litigation remains an open question for government customers.
The secondary market is voting. The IPO will be the real count.